Tcelltech
tcelltech.eu
Cell & Gene Therapy
Bioinformatics
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Helmholtz
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
| Legal entity | Tcelltech GmbH | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Immuneel is advancing access to breakthrough cancer therapies in India, for India and the world.. Cell, gene, and immunotherapies are…
About knowing01 knowing01 GmbH is a Munich-based life science software and analytics company founded in 2020. We help researchers in…
Game changing cancer immunotherapy We develop unique, T cell-recruiting antibody-therapy for patients suffering from solid tumors where…
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
Nucleovir Therapeutics is an AI-bio immuno-oncology company developing AI-designed, biologically validated cancer immunotherapies.
Overview
Tcelltech - Our Mission S/MARter Immunotherapies Our Mission Immunotherapies have revolutionized cancer therapies during the last decade, in a number of cases practically curing previously uncurable cancers. However, the majority of cancer patients still do not benefit from this revolution.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Mannheim
Germany
HQ
Impressum
Tcelltech GmbH, Franz-Volhard-Straße 5, 68167 Mannheim, Germany